Avidity Partners Management LP Akero Therapeutics, Inc. Transaction History
Avidity Partners Management LP
- $445 Million
- Q1 2025
A detailed history of Avidity Partners Management LP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 57,000 shares of AKRO stock, worth $3.13 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
57,000
Previous 82,000
30.49%
Holding current value
$3.13 Million
Previous $2.28 Million
1.14%
% of portfolio
0.52%
Previous 0.26%
Shares
8 transactions
Others Institutions Holding AKRO
# of Institutions
270Shares Held
86MCall Options Held
1.02MPut Options Held
823K-
Rtw Investments, LP New York, NY7.42MShares$408 Million4.92% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$389 Million0.16% of portfolio
-
Wellington Management Group LLP Boston, MA5.94MShares$326 Million0.05% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$307 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$288 Million7.15% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.55B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...